These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38584489)

  • 21. Influence of antithrombotic agents on the recurrence of chronic subdural hematomas and the quest about the recommencement of antithrombotic agents: A meta-analysis.
    Wang Y; Zhou J; Fan C; Wang D; Jiao F; Liu B; Zhang Q
    J Clin Neurosci; 2017 Apr; 38():79-83. PubMed ID: 28038831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Antithrombotic Medications and Reversal Strategies on the Surgical Management and Outcomes of Traumatic Acute Subdural Hematoma.
    Vattipally VN; Ran KR; Giwa GA; Myneni S; Dardick JM; Rincon-Torroella J; Ye X; Byrne JP; Suarez JI; Lin SC; Jackson CM; Mukherjee D; Gallia GL; Huang J; Weingart JD; Azad TD; Bettegowda C
    World Neurosurg; 2024 Feb; 182():e431-e441. PubMed ID: 38030067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of antithrombotic therapy on the recurrence and outcome of chronic subdural hematoma after burr-hole craniostomy in a population-based cohort.
    Kerttula S; Huttunen J; Leinonen V; Kämäräinen OP; Danner N
    Acta Neurochir (Wien); 2022 Oct; 164(10):2699-2708. PubMed ID: 35972559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of admission platelet count with current medications and the risk for chronic subdural recurrence.
    Eagle SR; Mittal AM; Kellogg RT; Vargas J; Nwachuku E; Deng H; Buell TJ; Okonkwo DO; Pease M
    Neurosurg Focus; 2023 Oct; 55(4):E4. PubMed ID: 37778037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of risk factors for chronic subdural haematoma recurrence after burr hole surgery: optimal management of patients on antiplatelet therapy.
    Okano A; Oya S; Fujisawa N; Tsuchiya T; Indo M; Nakamura T; Chang HS; Matsui T
    Br J Neurosurg; 2014 Apr; 28(2):204-8. PubMed ID: 23952136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trial.
    Kolias AG; Edlmann E; Thelin EP; Bulters D; Holton P; Suttner N; Owusu-Agyemang K; Al-Tamimi YZ; Gatt D; Thomson S; Anderson IA; Richards O; Whitfield P; Gherle M; Caldwell K; Davis-Wilkie C; Tarantino S; Barton G; Marcus HJ; Chari A; Brennan P; Belli A; Bond S; Turner C; Whitehead L; Wilkinson I; Hutchinson PJ;
    Trials; 2018 Dec; 19(1):670. PubMed ID: 30514400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrence in 787 Patients with Chronic Subdural Hematoma: Retrospective Cohort Investigation of Associated Factors Including Direct Oral Anticoagulant Use.
    Motoie R; Karashima S; Otsuji R; Ren N; Nagaoka S; Maeda K; Ikai Y; Uno J; Gi H
    World Neurosurg; 2018 Oct; 118():e87-e91. PubMed ID: 29945004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of recurrence of chronic subdural haematoma in a cohort study of patients presenting in a sub-Saharan African teaching hospital.
    Abdullah HM; Dakurah T; Akoto H; Abaidoo B; Dakubo JCB; Yawson AE; Wepeba G; Bankah P; Boatey J; Ametefe M; Nketiah-Boakye F; Fuseini A; Banson M; Ndanu T; Mubarak A; Iddrissu M
    BMC Neurol; 2022 Sep; 22(1):346. PubMed ID: 36104782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Embolization of the middle meningeal artery in patients with chronic subdural hematoma-a systematic review and meta-analysis.
    Haldrup M; Ketharanathan B; Debrabant B; Schwartz OS; Mikkelsen R; Fugleholm K; Poulsen FR; Jensen TSR; Thaarup LV; Bergholt B
    Acta Neurochir (Wien); 2020 Apr; 162(4):777-784. PubMed ID: 32086603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of discontinuation of antithrombotic therapy after surgery for chronic subdural hematoma.
    Todeschi J; Ferracci FX; Metayer T; Gouges B; Leroy HA; Hamdam N; Bougaci N; De Barros A; Timofeev A; Pretat PH; Bannwarth M; Roblot P; Peltier C; Lleu M; Pommier B; Chibbaro S; Proust F; Cebula H
    Neurochirurgie; 2020 Aug; 66(4):195-202. PubMed ID: 32645393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomised, double blind, placebo-controlled trial of a two-week course of dexamethasone for adult patients with a symptomatic Chronic Subdural Haematoma (Dex-CSDH trial).
    Hutchinson PJ; Edlmann E; Hanrahan JG; Bulters D; Zolnourian A; Holton P; Suttner N; Agyemang K; Thomson S; Anderson IA; Al-Tamimi Y; Henderson D; Whitfield P; Gherle M; Brennan PM; Allison A; Thelin EP; Tarantino S; Pantaleo B; Caldwell K; Davis-Wilkie C; Mee H; Warburton EA; Barton G; Chari A; Marcus HJ; Pyne S; King AT; Belli A; Myint PK; Wilkinson I; Santarius T; Turner C; Bond S; Kolias AG;
    Health Technol Assess; 2024 Mar; 28(12):1-122. PubMed ID: 38512045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic Subdural Hematoma.
    Hamou HA; Clusmann H; Schulz JB; Wiesmann M; Altiok E; Höllig A
    Dtsch Arztebl Int; 2022 Mar; 119(12):208-213. PubMed ID: 35236548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative MRI characteristics predict chronic subdural haematoma postoperative recurrence: a meta-analysis.
    Sherrod BA; Baker C; Gamboa N; McNally S; Grandhi R
    Br J Neurosurg; 2021 Oct; 35(5):527-531. PubMed ID: 33779443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-crescent sign as a predictor of chronic subdural hematoma recurrence following burr-hole surgery.
    Miki K; Abe H; Morishita T; Hayashi S; Yagi K; Arima H; Inoue T
    J Neurosurg; 2019 Dec; 131(6):1905-1911. PubMed ID: 30611142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The management and outcome for patients with chronic subdural hematoma: a prospective, multicenter, observational cohort study in the United Kingdom.
    Brennan PM; Kolias AG; Joannides AJ; Shapey J; Marcus HJ; Gregson BA; Grover PJ; Hutchinson PJ; Coulter IC;
    J Neurosurg; 2017 Mar; ():1-8. PubMed ID: 28306417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postoperative neutrophil-to-lymphocyte ratio variation is associated with chronic subdural hematoma recurrence.
    de Oliveira AJM; Solla DJF; de Oliveira KF; Amaral BS; Andrade AF; Kolias AG; Paiva WS
    Neurol Sci; 2022 Jan; 43(1):427-434. PubMed ID: 33891187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and Radiological Characteristics for Recurrence of Chronic Subdural Hematoma: A Systematic Review and Meta-Analysis.
    Mishra R; Deora H; Florez-Perdomo WA; Moscote-Salazar LR; Garcia-Ballestas E; Rahman MM; Shrivastava A; Raj S; Chavda V; Montemurro N; Agrawal A
    Neurol Int; 2022 Aug; 14(3):683-695. PubMed ID: 36135992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Characteristics and Current Managements for Patients with Chronic Subdural Hematoma : A Retrospective Multicenter Pilot Study in the Republic of Korea.
    Oh HJ; Seo Y; Choo YH; Kim YI; Kim KH; Kwon SM; Lee MH; Chong K
    J Korean Neurosurg Soc; 2022 Mar; 65(2):255-268. PubMed ID: 34727680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic subdural haematoma associated with disturbance of consciousness: significance of acute-on-chronic subdural haematoma.
    Honda Y; Sorimachi T; Momose H; Takizawa K; Inokuchi S; Matsumae M
    Neurol Res; 2015 Nov; 37(11):985-92. PubMed ID: 26344395
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.